Schistosomiasis Treatment Insights

Proziquantel is the primary drug used to treat schistosomiasis, effectively eliminating adult worms with a single dose. However, it does not target larval stages or prevent reinfection, raising concerns about potential drug resistance, particularly in immature schistosomes exposed to the drug. While current evidence shows it remains effective in human populations, the implications of resistance observed in mouse models warrant attention.